
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective
Shailendra K. Saxena, Swatantra Kumar, Saniya Ansari, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1738-1744
Closed Access | Times Cited: 289
Shailendra K. Saxena, Swatantra Kumar, Saniya Ansari, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1738-1744
Closed Access | Times Cited: 289
Showing 1-25 of 289 citing articles:
Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines
Yusha Araf, F. Akter, Yan‐Dong Tang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1825-1832
Open Access | Times Cited: 781
Yusha Araf, F. Akter, Yan‐Dong Tang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1825-1832
Open Access | Times Cited: 781
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 273
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 273
Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 199
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 199
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events
Junxian Ou, Wendong Lan, Xiaowei Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 187
Junxian Ou, Wendong Lan, Xiaowei Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 187
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments
Donia Bouzid, Benoît Visseaux, Christian Kassasseya, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 6, pp. 831-837
Open Access | Times Cited: 174
Donia Bouzid, Benoît Visseaux, Christian Kassasseya, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 6, pp. 831-837
Open Access | Times Cited: 174
Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain
Gang Ye, Bin Liu, Fang Li
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 117
Gang Ye, Bin Liu, Fang Li
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 117
New Coronavirus Variants are Creating More Challenges to Global Healthcare System: A Brief Report on the Current Knowledge
Salsabil Islam, Towhidul Islam, Md. Rabiul Islam
Clinical Pathology (2022) Vol. 15
Open Access | Times Cited: 116
Salsabil Islam, Towhidul Islam, Md. Rabiul Islam
Clinical Pathology (2022) Vol. 15
Open Access | Times Cited: 116
Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models
Lena Mautner, Mona Hoyos, Alexandra Dangel, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 96
Lena Mautner, Mona Hoyos, Alexandra Dangel, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 96
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
Naoko Iwata‐Yoshikawa, Masatoshi Kakizaki, Nozomi Shiwa-Sudo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 80
Naoko Iwata‐Yoshikawa, Masatoshi Kakizaki, Nozomi Shiwa-Sudo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 80
An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
V. Edwin Hillary, Stanislaus Antony Ceasar
Heliyon (2023) Vol. 9, Iss. 3, pp. e13952-e13952
Open Access | Times Cited: 76
V. Edwin Hillary, Stanislaus Antony Ceasar
Heliyon (2023) Vol. 9, Iss. 3, pp. e13952-e13952
Open Access | Times Cited: 76
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
Nina Breinholt Stærke, Joanne Reekie, Henrik Nielsen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 69
Nina Breinholt Stærke, Joanne Reekie, Henrik Nielsen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 69
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection
Mireille Farjo, Katia Koelle, Michael A. Martin, et al.
Journal of Virology (2024) Vol. 98, Iss. 1
Open Access | Times Cited: 17
Mireille Farjo, Katia Koelle, Michael A. Martin, et al.
Journal of Virology (2024) Vol. 98, Iss. 1
Open Access | Times Cited: 17
Case fatality rates of COVID‐19 during epidemic periods of variants of concern: A meta-analysis by continents
Qianhang Xia, Yujie Yang, Fengling Wang, et al.
International Journal of Infectious Diseases (2024) Vol. 141, pp. 106950-106950
Open Access | Times Cited: 14
Qianhang Xia, Yujie Yang, Fengling Wang, et al.
International Journal of Infectious Diseases (2024) Vol. 141, pp. 106950-106950
Open Access | Times Cited: 14
Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
Jianguo Zhang, Nan Chen, Daguo Zhao, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 61
Jianguo Zhang, Nan Chen, Daguo Zhao, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 61
Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1
Qibin Geng, Ke Shi, Gang Ye, et al.
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 57
Qibin Geng, Ke Shi, Gang Ye, et al.
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 57
Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination
Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 8, pp. 1372-1381
Open Access | Times Cited: 56
Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 8, pp. 1372-1381
Open Access | Times Cited: 56
Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions
Manojit Bhattacharya, Ashish Ranjan Sharma, Kuldeep Dhama, et al.
GeroScience (2022) Vol. 44, Iss. 2, pp. 619-637
Open Access | Times Cited: 56
Manojit Bhattacharya, Ashish Ranjan Sharma, Kuldeep Dhama, et al.
GeroScience (2022) Vol. 44, Iss. 2, pp. 619-637
Open Access | Times Cited: 56
Literature Review of Omicron: A Grim Reality Amidst COVID-19
Suraj Arora, Vishakha Grover, Priyanka Saluja, et al.
Microorganisms (2022) Vol. 10, Iss. 2, pp. 451-451
Open Access | Times Cited: 49
Suraj Arora, Vishakha Grover, Priyanka Saluja, et al.
Microorganisms (2022) Vol. 10, Iss. 2, pp. 451-451
Open Access | Times Cited: 49
Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity
Sandy Joung, Joseph E. Ebinger, Nancy Sun, et al.
JAMA Network Open (2022) Vol. 5, Iss. 8, pp. e2227241-e2227241
Open Access | Times Cited: 44
Sandy Joung, Joseph E. Ebinger, Nancy Sun, et al.
JAMA Network Open (2022) Vol. 5, Iss. 8, pp. e2227241-e2227241
Open Access | Times Cited: 44
Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus‐2 Omicron Variant of Concern
Shailendra K. Saxena, Swatantra Kumar, Saniya Ansari, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2160-2166
Open Access | Times Cited: 43
Shailendra K. Saxena, Swatantra Kumar, Saniya Ansari, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2160-2166
Open Access | Times Cited: 43
Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial
Laura Raniere Borges dos Anjos, Adeliane Castro da Costa, Amanda da Rocha Oliveira Cardoso, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Laura Raniere Borges dos Anjos, Adeliane Castro da Costa, Amanda da Rocha Oliveira Cardoso, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Is Omicron the end of pandemic or start of a new innings?
Swarnali Das, Sovan Samanta, Jhimli Banerjee, et al.
Travel Medicine and Infectious Disease (2022) Vol. 48, pp. 102332-102332
Open Access | Times Cited: 43
Swarnali Das, Sovan Samanta, Jhimli Banerjee, et al.
Travel Medicine and Infectious Disease (2022) Vol. 48, pp. 102332-102332
Open Access | Times Cited: 43